Displaying 541 - 560 of 853
| Active Ingredient | BETAMETHASONE DISODIUM PHOSPHATE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications |
Local treatment of inflammation. Must be prescribed by an ophthalmologIst. |
| Caution | Use for short periods of time. Prolonged use can cause herpetic corneal disease and "steroid glaucoma". |
| Dose Range | One drop 4 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BUDESONIDE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Rhinitis. |
| Caution | Not recommendedin children under 6 years. Non-halogenated corticosteroid. See under beclomethasone. |
| Dose Range | Adults and Children over 6 years: 2 sprays into each nostril oncedaily in the morning or 1 spray into each nostril twice daily; maintainence: 1 spray into each nostril once daily . See BDS supply protocols pg. 11. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DEXAMETHASONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Short term treatment of inflammation. Must be prescribed by an ophthalmologist. |
| Caution | |
| Dose Range | One drop 4 times daily |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUNISOLIDE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Prophylaxis and treatment of allergic rhinitis. |
| Caution | Loss of taste or smell, nausea, vomiting, dyspepsia, headache, dizziness, nasal irritation. |
| Dose Range | Adult and children 14 years and over: 2 spray s (25mcg/sp ray ) in each nostril twice daily , increased if necessary to max. 3 times daily then reduced for maintenance. Pediatric 5-14 years: Initially 1 sp ray (25mcg) into each nostril up to 3 time |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUOROMETHOLONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Allergic and inflammatory conditions of the eye. |
| Caution | Raised intra-ocular pressure with prolonged use. |
| Dose Range | Adult and children over 2: Apply every 1 hour for 24-48 hours, then reduced to 2-4 times a day . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | FLUTICASONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Prophylaxis and treatment of allergic rhinitis and perennial rhinitis and nasal polyps. |
| Caution | Nasal ulceration, dryness, irritation of nose and throat, and epistaxis. Not recommended in children under 2 y ears. |
| Dose Range |
Adults and children over 12 years: 2 sp ray s (55mcg) in each nostril once daily , reducing to 1 sp ray (27.5mcg) once daily once adequate control of symptoms is achieved. Pediatric 2 -12 years: 1 spray in each nostril once daily . See BDS supply pr |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MOMETASONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Prophylaxis and treatment of allergic rhinitis |
| Caution | Headache, pharyngitis, epistaxis, cough, dysmenorrhea, nasal burning. Store spray away from light. |
| Dose Range | Adults and children 12 years and over: 2 sp ray s in each nostril once daily , increasing to 4 sp ray s once daily if needed. Decrease to one sp ray once daily as a maintenance dose. Pediatric (2-11 years): 1 sp ray into each nostril once da |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PREDNISOLONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Long-term therap y should be avoided. |
| Caution | Long-term therap y should be avoided. |
| Dose Range | 1-2 drops every hour during the day and every 2 hours during the night for initial therapy in severe cases. In mild or moderate inflammation or when a favorable resp onse is attained in severe cases, dosage may be reduced to 1 or 2 drops every |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TRIAMCINOLONE |
| Therapeutic Class | EENT ANTI-INFLAMMATORY AGENTS |
| Indications | Treatment of seasonal and perennial allergic rhinitis. |
| Caution | Headache occurred in 18% of patients receiving intranasal triamcinolone. Other adverse effects included nasal irritation, dry mucous membranes, congestion, throatdiscomfort, sneezing. No More ... |
| Dose Range | Adults and Children 12 years and over: 2 sprays in each nostril once daily, decrease to one spray once daily as a maintenance dose. Pediatric (6-12 years): 1 sp ray into each nostril once daily. See BDS supply protocols pg. 11. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | KETOROLAC |
| Therapeutic Class | EENT NSAID |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | NEPAFENAC |
| Therapeutic Class | EENT NSAID |
| Indications | Extraction of cataract, inflammatory disorder of the eye, pain. |
| Caution | Vitreous detachment, conjunctival oedema, dry ey e, foreign body sensation, itching of eye, light intolerance, hyperemia, increased intraocular pressure, decreased visual acuity , sinusitis. |
| Dose Range |
Adult and Children 10 years and over: 1 drop in affected ey e(s) three times a day starting 1 day prior to cataract surgery, continued on the day of surgery and through the first 2 weeks of the post operative period. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | CYCLOSPORIN |
| Therapeutic Class | EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | DICLOFENAC SODIUM |
| Therapeutic Class | EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS |
| Indications | Cataract extracation, eye pain, refractive keratoplasty . |
| Caution | Transient burning and stinging, keratitis and elevated intraocular pressure, peripheral corneal infiltrates. Ophthalmic diclofenac solution should not be used with soft contact lenses but m More ... |
| Dose Range | Extraction of cataract: 1 drop into affected eye four times a day for 14 days, begin 24 hours post op. Filamentary Keratitis: 1 drop into affected ey e four times a day for 28 day s. Light intolerance, eye p ain, refractive keratop l |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | OXYBUPROCAINE |
| Therapeutic Class | EENT LOCAL ANESTHETIC |
| Indications | Topical anaesthesia. |
| Caution | Minims should be discarded after a single use. Not to be used as an ocular analgesic, may predisp ose to corneal ulceration. |
| Dose Range | 1-3 drops into conjunctival sac to anaesthetise surface of the eye. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PROPARACAINE |
| Therapeutic Class | EENT LOCAL ANESTHETIC |
| Indications | Rapid and short acting topical anaesthesia. |
| Caution | Warn patient not to rub eyes, not painful while causing an abrasion. |
| Dose Range | 1-2 drops at intervals as required to obtain adequate anaesthesia. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | ATROPINE SULPHATE |
| Therapeutic Class | EENT MYDRIATICS |
| Indications | Refraction procedures and in anterior uveitis. |
| Caution | Risk of systemic effects with eye drops in infants under 3 months. |
| Dose Range | Adult: 1 drop 1 hour before refraction procedure. Uveitis: 1-2 drops up to 4 times daily. Pediatric 3months-18yrs: 1 drop twice daily for 3 days before refraction procedure. Anterior uveitis (2-18 yrs): 1 drop up to 4 times daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | HOMATROPINE |
| Therapeutic Class | EENT MYDRIATICS |
| Indications | See Atrop ine Sulphate. |
| Caution | Burning, stinging. |
| Dose Range |
Adult: 1-2 drops immediately before procedure, repeat in 5-10 minutes if necessary . Uveitis: 1-2 drop s 2-3 times daily or up to every 3 or 4 hours. Pediatric 2yrs and over: 1 drop twice daily . |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PHENYLEPHRINE |
| Therapeutic Class | EENT MYDRIATICS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | TROPICAMIDE |
| Therapeutic Class | EENT MYDRIATICS |
| Indications | For mydriasis and cycloplegia for diagnostic procedures; pre and post operative eye surgery . |
| Caution | Blurred vision, ocular irritation, headache. Advise patient not to drive or engage in hazardous activity while pupils are dilated. Contra-indicated in narrow angle glaucoma. |
| Dose Range | For refraction: 1 or 2 drops. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | BENZYDAMINE |
| Therapeutic Class | MOUTH WASHES AND GARGLES |
| Indications | Inflammatory conditions of the mouth and throat. |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |